RGEN
$175.42-4.75%
Repligen CorporationStock · HealthcareNasdaq Composite 0.02%Russell 1000 0.01%Russell 3000 0.01%US Stock Market 0.01%
RGEN financial statements
The full income statement, balance sheet, and cash-flow statement for Repligen Corporation (RGEN), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 56.0M2024-09 56.0M2024-12 56.1M2025-03 56.2M2025-06 56.3M2025-09 56.3M2025-12 56.3M2026-03 56.4M2026-06 56.4M+0.8% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
As-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 738M+16.4% | 634M+0.3% | 632M-21.1% | 802M+19.5% | 671M+83.1% | |
| Cost of revenue | 352M-2.2% | 360M+1.7% | 354M+2.3% | 346M+23.8% | 279M+78.3% | |
| Research & development | 54.2M+25.4% | 43.2M+1.1% | 42.7M-2.8% | 43.9M+28.2% | 34.3M+69.8% | |
| Selling, general & administrative | 291M+10.3% | 263M+20.5% | 219M+1.3% | 216M+17.4% | 184M+53.7% | |
| Amortization of intangibles | 39.1M+12.7% | 34.7M+9.8% | 31.6M+16.6% | 27.1M+22.6% | 22.1M+37.3% | |
| Provision for credit losses | — | 155K+118.5% | -839K-1033.8% | -74.0K+91.1% | -828K-144.2% | |
| Operating income | 55.2M+257.1% | -35.1M-173.6% | 47.7M-78.8% | 225M+34.3% | 167M+139.5% | |
| Interest expense | 21.5M+3.8% | 20.7M+962.6% | 1.95M+67.9% | 1.16M-89.7% | 11.3M+4.7% | |
| Other non-operating income | 2.81M+154.4% | -5.17M-163.7% | 8.12M+185.2% | -9.53M-716.0% | -1.17M-445.8% | |
| Pre-tax income | 62.4M+330.7% | -27.0M-147.7% | 56.7M-74.1% | 219M+42.7% | 154M+159.3% | |
| Income tax | 13.5M+986.9% | -1.52M-107.2% | 21.1M-36.4% | 33.2M+31.4% | 25.3M+3661.6% | |
| Net income | 48.9M+291.6% | -25.5M-171.7% | 35.6M-80.9% | 186M+45.0% | 128M+114.1% | |
| $0.86+287.0% | -$0.46-173.0% | $0.63-80.6% | $3.24+44.6% | $2.24+101.8% | ||
| EPS (basic) | $0.87+289.1% | -$0.46-171.9% | $0.64-80.9% | $3.35+43.8% | $2.33+104.4% | |
| Weighted-avg shares (basic) | — | — | — | — | 55.0M+4.7% | |
| Weighted-avg shares (diluted) | — | — | — | — | 57.3M+6.3% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 1.14B+6.7% | 1.07B-4.1% | 1.11B+11.3% | 998M+7.1% | 932M+3.2% | ||
| Cash & equivalents | 566M-25.3% | 757M+0.8% | 751M+43.5% | 523M-13.3% | 604M-15.8% | |
| Short-term investments | 202M | 0.00 | — | — | — | |
| Accounts receivable | 159M+18.2% | 134M+8.0% | 124M+6.8% | 116M-1.0% | 117M+64.5% | |
| Inventory | 170M+19.2% | 143M-29.3% | 202M-15.1% | 238M+29.2% | 184M+94.2% | |
| Prepaid expenses | 40.7M+28.8% | 31.6M-5.8% | 33.5M+69.1% | 19.8M-23.6% | 25.9M+38.9% | |
| Other current assets | 21.6M+77.8% | 12.1M-8.9% | 13.3M+29.6% | 10.3M+22.2% | 8.41M-11.4% | |
| 2.95B+4.2% | 2.83B-0.1% | 2.83B+11.8% | 2.53B+7.3% | 2.36B+23.9% | ||
| Property, plant & equipment | 187M-5.6% | 198M-4.7% | 207M+8.8% | 191M+52.6% | 125M+86.9% | |
| Operating lease right-of-use | 120M-11.7% | 135M+17.2% | 116M-7.6% | 125M+23.1% | 102M+303.4% | |
| Goodwill | 1.11B+8.1% | 1.03B+4.4% | 987M+15.4% | 856M-0.6% | 860M+39.1% | |
| Intangible assets | 386M-3.0% | 398M-2.2% | 407M+12.8% | 361M+6.9% | 337M+17.5% | |
| Deferred tax assets | 694K-7.3% | 749K-51.0% | 1.53M+82.1% | 840K-55.9% | 1.90M-23.3% | |
| Other non-current assets | 4.91M+466.0% | 868K-32.0% | 1.28M+56.7% | 815K+32.5% | 615K+7.3% | |
| Total non-current assets | 1.81B+2.8% | 1.76B+2.5% | 1.72B+12.2% | 1.53B+7.5% | 1.43B+42.6% | |
| 136M+7.1% | 127M-23.1% | 165M-59.2% | 404M+7.7% | 375M+17.7% | ||
| Accounts payable | 30.0M-6.6% | 32.1M+64.3% | 19.6M-29.0% | 27.6M-23.9% | 36.2M+114.5% | |
| Accrued liabilities | 79.2M+26.9% | 62.4M+8.9% | 57.3M-19.4% | 71.1M-5.8% | 75.5M+42.2% | |
| Deferred revenue | 14.6M+10.3% | 13.2M-22.4% | 17.1M-11.5% | 19.3M+31.4% | 14.7M-4.2% | |
| Current lease liability | 21.6M+42.7% | 15.1M+168.2% | 5.63M-19.1% | 6.96M-16.2% | 8.30M+58.0% | |
| 844M-1.6% | 857M-1.1% | 866M+39.5% | 621M+2.1% | 608M+62.8% | ||
| Long-term debt | 542M+3.2% | 526M | — | — | — | |
| Non-current lease liability | 126M-13.3% | 146M+15.0% | 127M-3.7% | 131M+28.2% | 102M+287.9% | |
| Operating lease liability (total) | 148M-8.1% | 161M+21.5% | 132M-4.4% | 138M+24.8% | 111M+249.7% | |
| Other non-current liabilities | 15.6M-6.2% | 16.6M+47.0% | 11.3M+4.9% | 10.8M+282.1% | 2.81M+112.6% | |
| Total non-current liabilities | 708M-3.1% | 730M+4.1% | 701M+223.7% | 217M-7.0% | 233M+325.4% | |
| 2.11B+6.8% | 1.97B+0.4% | 1.96B+2.8% | 1.91B+9.2% | 1.75B+14.4% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 563K+0.4% | 561K+0.5% | 558K+0.4% | 556K+0.5% | 553K+0.9% | |
| Additional paid-in capital | 1.65B+2.1% | 1.62B+3.1% | 1.57B+1.4% | 1.55B-1.6% | 1.57B+7.6% | |
| Retained earnings | 456M+12.0% | 407M-5.9% | 433M+9.0% | 397M+104.7% | 194M+195.1% | |
| Accumulated other comprehensive income | -2.53M+95.2% | -52.5M-38.9% | -37.8M-9.9% | -34.4M-103.7% | -16.9M-909.9% | |
| Total liabilities & equity | 2.95B+4.2% | 2.83B-0.1% | 2.83B+11.8% | 2.53B+7.3% | 2.36B+23.9% | |
| Common shares issued | 56.3M+0.4% | 56.1M+0.6% | 55.8M+0.4% | 55.6M+0.4% | 55.3M+1.0% | |
| Common shares outstanding | 56.3M+0.4% | 56.1M+0.6% | 55.8M+0.4% | 55.6M+0.4% | 55.3M+1.0% | |
| Shares outstanding (cover) | 56.3M+0.3% | 56.1M+0.7% | 55.8M+0.4% | 55.6M+0.4% | 55.3M+1.0% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 117M-33.1% | 175M+54.0% | 114M-33.8% | 172M+44.6% | 119M+90.0% | ||
| Depreciation & amortization | 78.7M+13.0% | 69.7M+1.6% | 68.6M+34.5% | 51.0M+32.6% | 38.4M+42.0% | |
| Intangible amortization | 39.1M+12.7% | 34.7M+9.8% | 31.6M+16.6% | 27.1M+22.6% | 22.1M+37.3% | |
| Share-based compensation | 32.6M-32.2% | 48.1M+88.0% | 25.6M-6.4% | 27.3M-0.7% | 27.5M+61.7% | |
| Deferred income taxes | -3.37M+79.9% | -16.8M-1528.9% | 1.18M+186.9% | -1.35M-120.7% | 6.52M+263.3% | |
| Change in receivables | 17.2M+22.3% | 14.0M+323.6% | 3.31M-7.9% | 3.60M-92.3% | 46.5M+122.7% | |
| Change in inventory | 14.9M+126.3% | -56.9M-38.9% | -41.0M-171.6% | 57.2M-36.3% | 89.8M+199.3% | |
| Change in payables | -4.15M-132.2% | 12.9M+231.6% | -9.80M-19.6% | -8.20M-142.0% | 19.5M+693.0% | |
| -298M-245.5% | -86.4M+29.9% | -123M+47.1% | -233M-5.5% | -221M-9.8% | ||
| Capital expenditure | 23.5M-8.4% | 25.7M-29.1% | 36.2M-57.3% | 84.8M+26.4% | 67.1M+198.8% | |
| Free cash flow | 93.9M-37.3% | 150M+92.7% | 77.7M-10.9% | 87.2M+68.0% | 51.9M+29.3% | |
| Acquisitions | 70.3M+28.4% | 54.8M-70.7% | 187M | 0.00-100.0% | 150M-14.4% | |
| Sales/maturities of investments | 0.00 | 0.00-100.0% | 102M | 0.00 | 0.00 | |
| Proceeds from sale of PP&E | 238K | 0.00 | 0.00 | — | — | |
| Other investing activities | 2.40M+286.2% | -1.29M-3921.9% | -32.0K+70.9% | -110K | 0.00 | |
| -15.2M+81.7% | -82.9M-133.3% | 249M+1966.7% | -13.3M-1487.8% | 961K-99.7% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Common stock repurchased | 0.00 | 0.00-100.0% | 14.4M | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other financing activities | 0.00 | 0.00+100.0% | -45.0K-73.1% | -26.0K-23.8% | -21.0K | |
| FX effect on cash | — | — | — | — | -12.3M-196.5% | |
| Net change in cash | -191M-3272.0% | 6.03M-97.4% | 228M+383.6% | -80.4M+29.2% | -113M-163.1% | |
| Interest paid | — | 6.07M+514.4% | 988K-4.4% | 1.03M-3.1% | 1.07M+0.0% | |
| Income taxes paid | 20.9M+8.4% | 19.3M-28.5% | 27.0M-21.4% | 34.4M+108.1% | 16.5M+60.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 9.23B+14.2% | 8.08B-19.5% | 10.0B+6.8% | 9.40B-35.8% | 14.7B+39.6% | |
| P/E | 188.8× | — | 99.6×+76.3% | 56.5×-50.5% | 114.2×-34.8% | |
| P/S | 12.5×-1.9% | 12.7×-17.2% | 15.4×+31.1% | 11.7×-46.3% | 21.9×-23.7% | |
| P/B | 4.4×+7.0% | 4.1×-19.4% | 5.1×-0.7% | 5.1×-38.8% | 8.4×+22.0% | |
| P/FCF | 98.3×+82.1% | 54.0×-45.6% | 99.2×-33.2% | 148.5×-47.4% | 282.2×+8.0% | |
| Earnings yield | 0.53% | — | 1.0%-43.3% | 1.8%+102.1% | 0.88%+53.3% | |
| FCF yield | 1.0%-45.1% | 1.9%+83.8% | 1.0%+49.6% | 0.67%+90.0% | 0.35%-7.4% | |
| Source filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
About this data
Source: RGEN’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all RGEN filings on SEC EDGAR → Not investment advice.